R. Malessa

发表

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

M. Hanefeld, D. Ziegler, K. Ruhnau, 1999, Diabetes care.

Successful treatment of meningoencephalitis caused by Mycobacterium avium intracellulare in AIDS

H. Diener, N. Brockmeyer, T. Olbricht, 1994, The clinical investigator.

Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials.

R. Malessa, M. Überall, I. Dykukha, 2021, Pain medicine.

Acute Viral Infections of the Central Nervous System

K. Tyler, R. Malessa, 2003 .

The Goltz–Ferrier debates and the triumph of cerebral localizationalist theory

K. Tyler, R. Malessa, 2000, Neurology.

Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis

U. Hengge, U. Ravens, N. Brockmeyer, 1993, Antimicrobial Agents and Chemotherapy.

Magnetic Resonance Imaging-Guided Perineural Therapy as a Treatment Option in Young Adults with Pudendal Nerve Entrapment Syndrome

J. Schelhorn, R. Malessa, C. Dannenberg, 2013, Clinical Neuroradiology.

Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate

Dan Ziegler, D. Ziegler, M. Agelink, 2001, Clinical Autonomic Research.

Disseminated cerebral hemorrhages as unusual manifestation of toxoplasmic encephalitis in AIDS

O. Popescu, P. Berlit, R. Malessa, 1996, Journal of the Neurological Sciences.

Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis.

P. Faustmann, A. Eis-Hübinger, R. Malessa, 1995, Journal of neurovirology.

[Evoked potentials in neurologically asymptomatic persons during the early stages of HIV infection].

N. Brockmeyer, M. Goos, R. Malessa, 1989, EEG-EMG Zeitschrift fur Elektroenzephalographie, Elektromyographie und verwandte Gebiete.

Cardiovascular Autonomic Reactivity in Schizophrenics under Neuroleptic Treatment: A Potential Predictor of Short-Term Outcome?

E. Klieser, M. Agelink, R. Malessa, 1998, Neuropsychobiology.

Oligosymptomatic neurosyphilis with false negative CSF-VDRL in HIV-infected individuals?

U. Hengge, M. Gastpar, N. Brockmeyer, 1996, European journal of medical research.

Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy

U. Hengge, W. Rascher, M. Michel, 1996, Journal of the Neurological Sciences.

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

A. Gendolla, R. Malessa, B. Schäuble, 2010, Current medical research and opinion.

[Discordant syringomyelia twins in familial syringomyelia].

R. Malessa, J. Jörg, 1986, Der Nervenarzt.

A functional-structural model to understand cardiac autonomic nervous system (ANS) dysregulation in affective illness and to elucidate the ANS effects of antidepressive treatment.

J. Cordes, A. Klimke, B. Baumann, 2004, European journal of medical research.

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS)

J. Hasford, N. Putzki, U. Zettl, 2007, Journal of Neurology.

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis.

J. Hasford, N. Putzki, U. Zettl, 2007, Journal of neurology.

Sensitivity of carbohydrate-deficient transferrin (CDT) in relation to age and duration of abstinence.

E. Klieser, M. Agelink, R. Malessa, 1998, Alcohol and alcoholism.

Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN)

E. Klieser, M. Agelink, R. Malessa, 1998, Journal of the Neurological Sciences.

Foscarnet treatment in various cytomegalovirus infections.

U. Hengge, R. Steinmetz, N. Brockmeyer, 1993, International journal of clinical pharmacology, therapy, and toxicology.

[Cerebral metabolic changes and chronic back pain: Study taking into consideration clinical and psychological parameters].

J. Reichenbach, B. Strauss, A. Gussew, 2016, Schmerz.

Neuro-AIDS

R. Malessa, 1996 .

Dysfunction of visual pathways in HIV-1 infection

H. Diener, M. Agelink, R. Malessa, 1995, Journal of Neurological Sciences.

ANTI-Rh(D) IMMUNOGLOBULIN FOR AIDS-RELATED THROMBOCYTOPENIA

W. Luboldt, R. Biniek, N. Brockmeyer, 1986, The Lancet.

Improved autonomic neurocardial balance in short-term abstinent alcoholics treated with acamprosate.

Marcus W. Agelink, E. Klieser, R. Malessa, 1998, Alcohol and alcoholism.

Improvement of neurocardial vagal dysfunction after successful antidepressive treatment with electroconvulsive therapy (ECT)

E. Klieser, M. Agelink, R. Malessa, 1998, European Psychiatry.

Nerve conduction changes in asymptomatic HIV-1 seropositive individuals in the absence of other risk factors for neuropathy.

T. Kloss, N. Brockmeyer, M. Agelink, 1996, Electromyography and clinical neurophysiology.